Multiple sclerosis

Jury still out on use of natalizumab for MS in late pregnancy

The jury is still out on the use of natalizumab in the latter stages of pregnancy in women with aggressive MS, say neurologists from WA. While the monoclonal antibody is considered safe in early pregnancy, it crosses the placenta in late pregnancy and has previously been associated with haematological abnormalities. According to a retrospective review ...

Already a member?

Login to keep reading.

© 2021 the limbic